Bankruptcy beckons Tengion
This article was originally published in Scrip
Executive Summary
Regenerative medicine specialist Tengion said in its second quarter 2012 financial report that if the company does not raise new capital soon "it will need to suspend its business operations and will likely need to seek protection under US bankruptcy laws".